Clinical Trial Update: Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial of quetiapine extended-release for major depressive disorder with comorbid generalized anxiety disorder was terminated, and results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Quetiapine XR (quetiapine)

Snippet

Sponsor: Keming Gao | Conditions: Major Depressive Disorder, Generalized Anxiety Disorder | Phase 3 | Status: TERMINATED | Results posted: 2014-02-11